Noel Courage and Nyrie Israelian coauthored the article “The scope of Canadian patented drug price review narrows”, published by The Life Sciences Lawyer

February 4, 2022

Subscribe to our newsletter

You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This site is registered on as a development site.